Author

M. Mallory

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Evolutionary Biology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 3 Approach:experimental assay· 2 Organism:mouse· 2 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1 Research Focus:variant calling· 1

Frequent Co-Authors

R. S. Baric· 3 shared A. Brown· 2 shared N. Catanzaro· 2 shared T. D. Scobey· 2 shared A. Newman· 1 shared A. R. Schaefer· 1 shared A. Schaefer· 1 shared A.-H. Nguyen· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

R. S. Baric

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Vaccine-mediated protection against merbecovirus and sarbecovirus challenge in mice

D. Martinez, A. R. Schaefer, T. Gavitt, M. Mallory, E. Lee, N. Catanzaro, H. Chen, K. Gully, T. D. Scobey, P. Korategere, A. Brown, L. Smith, R. Parks, M. Barr, A. Newman, , K. O. Saunders

This study develops a trivalent RBD nanoparticle vaccine that protects mice against both merbecovirus and sarbecovirus challenges, including SARS-CoV, MERS-CoV, and SARS-CoV-2.

Cell Reports · Oct 1, 2023Peer-reviewedImmunology

Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potential

D. R. Martinez, F. Moreira, M. R. Zweigart, K. L. Gully, G. De la Cruz, A. Brown, L. E. Adams, N. Catanzaro, B. Yount, T. J. Baric, M. Mallory, H. Conrad, S. R. May, S. Dong, T. D. Scobey, , T. P. Sheahan

This study evaluates the antiviral efficacy of GS-5245 against multiple SARS-CoV-2 variants and other coronaviruses, showing broad in vitro activity and protective effects in animal models.

bioRxiv · Jun 27, 2023 · PreprintMicrobiology

Preadaptation of pandemic GII.4 noroviruses in hidden virus reservoirs years before emergence

C. Ruis, L. Lindesmith, M. Mallory, P. D. Brewer-Jensen, J. Bryant, V. Costantini, C. Monit, J. Vinje, R. S. Baric, R. A. Goldstein, J. A. Breuer

This paper shows that GII.4 noroviruses preadapt and circulate undetected for years before causing a new pandemic, with changes in host immunity enabling spread rather than genetic changes alone.

bioRxiv · Jun 3, 2019Evolutionary Biology